Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
8
|
pubmed:dateCreated |
1983-1-7
|
pubmed:abstractText |
Pharmacokinetics of the sulphamerazine/trimethoprim-combination Berlocombin-200 was calculated by an one-compartment-model following therapeutic administration in pregnant women and compared with a control group. Distribution parameters are significantly changed, but elimination half-lifes of both the sulphonamide and trimethoprim are not influenced by repeated administration during pregnancy. There are no consequences concerning the dosage of Berlocombin in bacterial infections during pregnancy.
|
pubmed:language |
ger
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
0031-7144
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
37
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
578-83
|
pubmed:dateRevised |
2007-1-29
|
pubmed:meshHeading |
pubmed-meshheading:7146066-Drug Combinations,
pubmed-meshheading:7146066-Female,
pubmed-meshheading:7146066-Half-Life,
pubmed-meshheading:7146066-Humans,
pubmed-meshheading:7146066-Kinetics,
pubmed-meshheading:7146066-Pregnancy,
pubmed-meshheading:7146066-Sulfamerazine,
pubmed-meshheading:7146066-Trimethoprim
|
pubmed:year |
1982
|
pubmed:articleTitle |
[Studies on the pharmacokinetics of the compound preparation sulfamerazine/trimethoprim (Berlocombin-200) in pregnancy].
|
pubmed:publicationType |
Journal Article,
English Abstract
|